<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="220462">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00213720</url>
  </required_header>
  <id_info>
    <org_study_id>3463</org_study_id>
    <nct_id>NCT00213720</nct_id>
  </id_info>
  <brief_title>Treatment of Subclinical Hyperthyroidism</brief_title>
  <official_title>Place de l'Iode RadioActif Dans l'HyperThyroïdiE Sub-clinique (PIRHATES)/ Evaluation of the Interest of Subclinical Hyperthyroidism Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <brief_summary>
    <textblock>
      Objective: To determine if the treatment of subclinical hyperthyroidism will reduce the rate
      of atrial fibrillation, the main complication of this condition.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized open-labelled multicentre study comparing radioiodine vs medical supervision
      without treatment
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2005</start_date>
  <phase>Phase 4</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Subclinical Hyperthyroidism</condition>
  <condition>Atrial Fibrillation</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients referred to tertiary hospitals for advice on thyroïd disease
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women aged 50 and greater

          -  Isolated decreased thyroid-stimulating hormone (TSH) with normal FT4 and FT3 levels

        Exclusion Criteria:

          -  Iodide overload

          -  Non sinusal heart rhythm

          -  Severe heart disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernard Goichot, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bernard Goichot, MD</last_name>
    <phone>333 88 12 75 93</phone>
    <email>bernard.goichot@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Patrick Roger</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Roger, MD</last_name>
      <phone>335 57 65 64 33</phone>
      <email>patrick.roger@chu-bordeaux.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Philippe Thiéblot</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philippe Thiéblot, MD</last_name>
      <phone>334 73 75 15 33</phone>
      <email>pthieblot@chu-clermontferrand.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jean-Marcel Brun</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Marcel Brun</last_name>
      <phone>333 80 29 34 53</phone>
      <email>jean-marcel.brun@chu-dijon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jean-Louis Wemeau</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Louis Wemeau, MD</last_name>
      <phone>333 20 44 41 18</phone>
      <email>jl-wemeau@chru-lille.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marie-Pierre Teissier</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Pierre Teissier, MD</last_name>
      <phone>335 55 05 68 51</phone>
      <email>marie-pierre.teissier@chu-limoges.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jacques Orgiazzi</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacques Orgiazzi, MD</last_name>
      <phone>334 78 86 14 88</phone>
      <email>jacques.orgiazzi@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bernard Conte-Delvox</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bernard Conte-Delvox, MD</last_name>
      <phone>334 91 38 65 97</phone>
      <email>bernard.conte-delvox@ap-hm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH de Montbrison</name>
      <address>
        <city>Montbrison</city>
        <zip>42605</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luc Millot, MD</last_name>
      <phone>0033477967853</phone>
      <email>l.millot@ch-montbrison.fr</email>
    </contact>
    <investigator>
      <last_name>Luc Millot, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jacques Bringer</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacques Bringer</last_name>
      <phone>334 67 33 83 82</phone>
      <email>j-bringer@chu-montpellier.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marc Klein</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Klein</last_name>
      <phone>333 83 15 34 31</phone>
      <email>m.klein@chu-nancy.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Michel Rodier</name>
      <address>
        <city>Nimes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Rodier, MD</last_name>
      <phone>334 66 68 33 21</phone>
      <email>michel.rodier@chu-nimes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Laurence Leenhardt</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence Leenhardt, MD</last_name>
      <phone>331 42 17 62 81</phone>
      <email>laurence.leenhardt@psl.ap-hop-paris.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Richard Marechaud</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Marechaud</last_name>
      <phone>335 49 44 43 80</phone>
      <email>r.marechaud@chu-poitiers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brigitte Delemer</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brigitte Delemer, MD</last_name>
      <phone>333 26 78 75 33 / 79 42</phone>
      <email>brigitte.delemer@wanadoo.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Claire Schvartz</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire Schvartz, MD</last_name>
      <phone>333 26 50 43 21</phone>
      <email>claire.schvartz@reims.fnclcc.fr</email>
    </contact>
    <investigator>
      <last_name>Béatrice Maes, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Marie Pochart, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Didier Maugendre</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Didier Maugendre, MD</last_name>
      <phone>332 99 26 71 42</phone>
      <email>didier.maugendre@chu-rennes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jean-Marc Kuhn</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Marc Kuhn, MD</last_name>
      <phone>332 32 88 90 82</phone>
      <email>jean-marc.kuhn@chu-rouen.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bruno Estour</name>
      <address>
        <city>Saint-Etienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno Estour, MD</last_name>
      <phone>334 77 12 77 27</phone>
      <email>bruno.estour@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Luc Millot, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Paul Strauss</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Schneegans, MD</last_name>
      <phone>0033388252428</phone>
      <email>oschneegans@strasbourg.fnclcc.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier Schneegans, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernard Goichot, MD</last_name>
      <phone>333 88 12 75 93</phone>
      <email>bernard.goichot@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Louis Schlienger, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabienne Grunenberger, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alain Pradignac, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephane Vinzio, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Philippe Caron</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Caron</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pierre Lecomte</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Lecomte, MD</last_name>
      <phone>332 47 47 87.03</phone>
      <email>lecomte@med.univ-tours.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2007</verification_date>
  <lastchanged_date>April 19, 2012</lastchanged_date>
  <firstreceived_date>September 13, 2005</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hyperthyroidism</keyword>
  <keyword>atrial fibrillation</keyword>
  <keyword>quality of life</keyword>
  <keyword>radioiodine treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Hyperthyroidism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
